Company / Operating Cash Flow per Share
AGIOS PHARMACEUTICALS, INC. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$6.53
FY2025
5-year range
-$6.97 / -$5.35
FY2021-FY2025
Trend
+6.4%
vs FY2024
Sector context
#205 of 212
Health Care
What the data says
Among 212 Health Care companies, AGIOS PHARMACEUTICALS, INC. is in the bottom 3% for operating cash flow per share. Operating Cash Flow per Share returned to growth in FY2025 after 2 years of decline, reaching $-6.53.
Based on SEC 10-K filings.
-6.53 in FY2025.
Declined from $-5.38 to $-6.53 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 212This company -$6.53 Sector average $5.28
▼
-223.7% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 6.4% year-over-year.
- Ranks #205 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2016.
- Lowest operating cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.83 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$6.53 | +6.4% |
| FY2024 | -$6.97 | -29.5% |
| FY2023 | -$5.38 | -0.5% |
| FY2022 | -$5.35 | +20.6% |
| FY2021 | -$6.74 | -51.4% |
| FY2020 | -$4.45 | +30.1% |
| FY2019 | -$6.37 | -906.1% |
| FY2018 | $0.79 | +111.7% |
| FY2017 | -$6.76 | -760.4% |
| FY2016 | $1.02 | +167.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026